ESR1 and breast neoplasm: Interestingly, Martens et al. (2008) found that miR-7 and other three miRNAs were significantly associated with aggressiveness of estrogen receptor positive (ER+) primary breast tumors of patients with lymph node-negative (LNN) disease [15], suggesting that miR-7 may be an oncomiR.